Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Deal Watch: Allergan Deal-Binge Includes Derm, NASH Buys

Sep 22 2016

• By Joseph Haas

Business Balance - A businessman carrying paperwork walking over a tight rope.

Related Content

Tobira Says Secondary Endpoint In NASH Will Carry CVC Into Pivotal Study

Jul 25 2016

The NASH Pipeline: Replete With Targets And New Compounds

Aug 29 2016

Genentech, BioNTech Pact Aims To Make Targeted Cancer Vaccines

Sep 22 2016

Bayer Reiterates Pharma Commitment Post-Monsanto, Plays Up Pipeline

Sep 20 2016

Regeneron Partners NGF Antibody With Teva To Mitigate Risks

Sep 20 2016

Viventia's Cancer Ambitions Go To Eleven

Sep 21 2016

Allergan’s Tab For Tobira’s NASH Cocktail With Akarna Chaser Tops $1.7bn

Sep 21 2016

Could $639m Vitae Buy Give Allergan A New Autoimmune Focus?

Sep 15 2016

Pfizer Is Back In The CTLA-4 Game Via Pact With OncoImmune

Sep 15 2016

Related Companies

Allergan plc

Allergan plc

Intercept Pharmaceuticals, Inc.

Vitae Pharmaceuticals, Inc.

One Way Liver Genomics SL

Golden Meditech Holdings Limited

University of Texas MD Anderson Cancer Center

Bayer AG

Evotec SE

Ligand Pharmaceuticals, Inc.

Tarveda Therapeutics, Inc.

Madrigal Pharmaceuticals, Inc.

Madrigal Pharmaceuticals, Inc.

Leukocare AG

PaxVax Corporation

Additional Topics

Deals M & A Commercial Business Strategies BioPharmaceutical

More from Deals

More from Business

Twitter feed RSS feed RSS feed

About Us

Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us

Customer Service
SubscribeOpens in new window
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window

Copyright © 2025 Pharma Intelligence UK Limited (Citeline), a Norstella company Pharma Intelligence UK Limited is a company registered in England and Wales with company number 13787459 whose registered.